Sumhitha Meditech Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 05-11-2024
- Paid Up Capital ₹ 4.50 Cr
as on 05-11-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.00 Cr
as on 05-11-2024
- Revenue %
(FY 2023)
- Profit -11395.28%
(FY 2023)
- Ebitda -2283.59%
(FY 2023)
- Net Worth -59.16%
(FY 2023)
- Total Assets 20.01%
(FY 2023)
About Sumhitha Meditech
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹14.00 Cr.
Penubothu Muralidhar, Satya Gadde, Ohm Ravi, and One other member serve as directors at the Company.
- CIN/LLPIN
U17299TG2020PTC145407
- Company No.
145407
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sumhitha Meditech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Penubothu Muralidhar  | Director | 26-Mar-2021 | Current |
Satya Gadde  | Director | 26-Mar-2021 | Current |
| Ohm Ravi | Director | 29-Oct-2020 | Current |
| Manjusha Peddi | Director | 29-Oct-2020 | Current |
Financial Performance and Corporate Structure Insights of Sumhitha Meditech.
Sumhitha Meditech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 11395.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 59.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sumhitha Meditech?
In 2023, Sumhitha Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sumhitha Polyfabrics Private LimitedActive 8 years 4 monthsPenubothu Muralidhar, Ohm Ravi and 1 more are mutual person
Vizag Hospital And Cancer Research Centre Pvt LtdActive 38 years 9 monthsPenubothu Muralidhar is a mutual person
- Sampragna Projects Private LimitedActive 8 years 10 months
Ohm Ravi and Manjusha Peddi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Sep 2021 | ₹14.00 Cr | Open |
How Many Employees Work at Sumhitha Meditech?
Sumhitha Meditech has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sumhitha Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sumhitha Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
